High Dietary Antioxidant Intake is Associated with Changes in Gut Microbiome Composition and Predicted Metabolic Pathways in Parkinson’s Disease, but these Alterations were Not Associated with Shifts in Cognitive Performance

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by both motor and non-motor symptoms. In addition to the neuropathological and clinical features, increasing evidence suggests that the gut microbiome may contribute to PD pathophysiology through the gut-brain axis. Dietary antioxidants have gained increasing attention for their potential neuroprotective effects, which may be explained by their ability to modulate the gut microbiome and reduce oxidative stress. However, the relationship between antioxidant-driven microbiome changes and cognitive performance in PD remains poorly understood. This study investigated the effects of dietary antioxidants, including vitamins A, C, and E, alpha-carotene, beta-carotene, and their combined effects, on the gut microbiome and cognitive performance in PD patients. We analyzed 16S rRNA gene sequencing data from 197 fecal samples collected from PD patients, with cognitive performance assessed using the Montreal Cognitive Assessment (MoCA). Dietary antioxidant intake was standardized into Dietary Antioxidant Index, and PD patients were stratified into low, medium, and high intake tertiles accordingly. High antioxidant intake was associated with significant shifts in gut microbial community composition, as measured by beta diversity. Indicator species analysis identified Escherichia-Shigella as a biomarker of low beta-carotene and vitamin C intake groups, although its relative abundance was not significantly correlated with MoCA scores. Functional pathway analysis showed reduced abundance of predicted metabolic pathways in high beta-carotene and vitamin C intake groups, including pathways related to lipopolysaccharide biosynthesis, amino acid degradation, and oxidative stress detoxification. However, the microbiome composition of these significantly differentially abundant pathways was not associated with cognitive performance.

Authors

Institutions

Publication Details

Journal
Open Collections
Published
2026-10-16
DOI
https://doi.org/10.14288/ujemiplus.v12.203875
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High Dietary Antioxidant Intake is Associated with Changes in Gut Microbiome Composition and Predicted Metabolic Pathways in Parkinson’s Disease, but these Alterations were Not Associated with Shifts in Cognitive Performance

Cynthia Lin, Carrie Sun, Coe McGrath, Yanting Xiong et al.
Open Collections
Gut microbiota and health
article

High Dietary Antioxidant Intake is Associated with Changes in Gut Microbiome Composition and Predicted Metabolic Pathways in Parkinson’s Disease, but these Alterations were Not Associated with Shifts in Cognitive Performance

Cynthia Lin, Carrie Sun, Coe McGrath, Yanting Xiong, Emily Ju
article en

Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by both motor and non-motor symptoms. In addition to the neuropathological and clinical features, increasing evidence suggests that the gut microbiome may contribute to PD pathophysiology through the gut-brain axis. Dietary antioxidants have gained increasing attention for their potential neuroprotective effects, which may be explained by their ability to modulate the gut microbiome and reduce oxidative stress. However, the relationship between antioxidant-driven microbiome changes and cognitive performance in PD remains poorly understood. This study investigated the effects of dietary antioxidants, including vitamins A, C, and E, alpha-carotene, beta-carotene, and their combined effects, on the gut microbiome and cognitive performance in PD patients. We analyzed 16S rRNA gene sequencing data from 197 fecal samples collected from PD patients, with cognitive performance assessed using the Montreal Cognitive Assessment (MoCA). Dietary antioxidant intake was standardized into Dietary Antioxidant Index, and PD patients were stratified into low, medium, and high intake tertiles accordingly. High antioxidant intake was associated with significant shifts in gut microbial community composition, as measured by beta diversity. Indicator species analysis identified Escherichia-Shigella as a biomarker of low beta-carotene and vitamin C intake groups, although its relative abundance was not significantly correlated with MoCA scores. Functional pathway analysis showed reduced abundance of predicted metabolic pathways in high beta-carotene and vitamin C intake groups, including pathways related to lipopolysaccharide biosynthesis, amino acid degradation, and oxidative stress detoxification. However, the microbiome composition of these significantly differentially abundant pathways was not associated with cognitive performance.

Open Collections
University of British Columbia (CA)
Good health and well-being
Openalex Percentile: Top 23%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.